PortfoliosLab logo

Fulcrum Therapeutics, Inc. (FULC)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$8.51
  • Year Range$7.20 - $30.97
  • EMA (50)$12.10
  • EMA (200)$14.63
  • Average Volume$775.21K
  • Market Capitalization$352.93M

FULCShare Price Chart


Chart placeholderClick Calculate to get results

FULCPerformance

The chart shows the growth of $10,000 invested in Fulcrum Therapeutics, Inc. on Jul 19, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,304 for a total return of roughly -36.96%. All prices are adjusted for splits and dividends.


FULC (Fulcrum Therapeutics, Inc.)
Benchmark (^GSPC)

FULCReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-33.25%-12.57%
YTD-51.89%-18.14%
6M-50.47%-17.07%
1Y-12.81%-5.21%
5Y-14.97%9.74%
10Y-14.97%9.74%

FULCMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

FULCSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Fulcrum Therapeutics, Inc. Sharpe ratio is -0.08. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


FULC (Fulcrum Therapeutics, Inc.)
Benchmark (^GSPC)

FULCDividend History


Fulcrum Therapeutics, Inc. doesn't pay dividends

FULCDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


FULC (Fulcrum Therapeutics, Inc.)
Benchmark (^GSPC)

FULCWorst Drawdowns

The table below shows the maximum drawdowns of the Fulcrum Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Fulcrum Therapeutics, Inc. is 76.75%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.75%Sep 21, 2021162May 11, 2022
-70.05%Jul 30, 201959Oct 21, 201925Nov 25, 201984
-67.27%Jun 26, 202045Aug 28, 2020240Aug 12, 2021285
-57.15%Jan 14, 202057Apr 3, 202057Jun 25, 2020114
-26.98%Nov 26, 20197Dec 5, 201912Dec 23, 201919
-12.57%Dec 27, 20194Jan 2, 20204Jan 8, 20208
-11.72%Sep 1, 20219Sep 14, 20213Sep 17, 202112
-7.04%Jul 19, 20191Jul 19, 20195Jul 26, 20196
-5.19%Aug 16, 20211Aug 16, 20212Aug 18, 20213
-4.86%Aug 19, 20211Aug 19, 20211Aug 20, 20212

FULCVolatility Chart

Current Fulcrum Therapeutics, Inc. volatility is 70.38%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


FULC (Fulcrum Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Fulcrum Therapeutics, Inc.


Loading data...

More Tools for Fulcrum Therapeutics, Inc.